Navigation Links
Wayne State University Scientists ID New Biomarker for Prostate Cancer
Date:3/26/2009

DETROIT, March 26 /PRNewswire-USNewswire/ -- Researchers at Wayne State University have identified a new marker for prostate cancer progression that may one day lead to new treatments.

Prostate cancer, one of the most prevalent non-skin cancers in America, affects one in six men. In 2008, nearly two million Americans were being treated for prostate cancer; nearly 186,000 were newly diagnosed, and approximately 28,000 died from the disease.

Avraham Raz, professor of pathology and radiation oncology in the School of Medicine at Wayne State University and the Karmanos Cancer Institute, and his team of renowned research collaborators identified a cleaved form of galectin-3 as a marker for prostate cancer progression. According to the study published in the April 2009 issue of The American Journal of Pathology, previous research indicated that decreased levels of galectin-3 are linked with neoplastic progression in prostate cancer. However, increased levels of galectin-3 are believed to be associated with tumorigenicity in other tumor types.

The study found that cleaved galectin-3, an inheritable gene, is present in late-stage prostate cancer, and that by reducing levels of galectin-3, development of metastatic prostate cancer is inhibited. This finding suggests that galectin-3 may serve as both a diagnostic marker and therapeutic target for future prostate cancer treatments.

"Dr. Raz's brilliant research is leading us closer to discovering the genetic risk factors for developing not only prostate cancer, but other cancers as well," said Dr. Gloria Heppner, associate vice president for research at Wayne State. "His work at Wayne State and the Karmanos Cancer Institute is another example of the tremendous research we are doing to uncover the cause of this prevalent disease, which ultimately will lead to new treatments that will save lives."

Other School of Medicine researchers involved in this study include Drs. Yi Wang, Pratima Nangia-Makker, Vitaly Balan, Victor Hogan and Larry Tait. Dr. Kenneth J. Pienta of the departments of internal medicine and urology at the University of Michigan also collaborated in this study.

Wayne State University is one of the nation's pre-eminent public research universities in an urban setting, ranking in the top 50 in R & D expenditures of all public universities by the National Science Foundation. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. WSU's School of Medicine is the nation's largest single-campus medical school. Together with the Wayne State University Physician Group and 13 hospital partners, the school is a leader in medical education, biomedical research, and patient care. Its programs of excellence include cancer, maternal-child health, neurosciences, and population studies and urban health.


'/>"/>
SOURCE Wayne State University
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Blue Cross Blue Shield of Michigan Awards Grant to Reduce Accidental Infant Suffocations in Wayne County
3. Enova Medical Technologies Names Wayne Ramaker Vice President of Marketing and Communications
4. EPA Recognizes Fort Wayne Community Schools for Reducing Diesel Emissions From Its School Buses
5. 2008 Caregiving Conferences Come to Wayne County, Offering Free Workshops and Resources in Canton and Taylor Locations
6. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
7. Wayne County Medical Society Foundation To Host Holiday Party For Underprivileged Children Saturday
8. New Zealand Waynes New Resources Development Co., Ltd. Completes Reverse Merger to Go Public in the U.S.
9. Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute
10. Elder Abuse Prevention the Focus of Wayne County Medical Society Foundations Annual Chinese New Year Fundraiser
11. Wayne County Community College District Presents Second Annual Child Car Seat Check Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 30, 2016 , ... Mercy College ... campus. The following programs will be expanding due to high demand: Master of ... The expansion will begin this summer. , School of Business Graduate Program ...
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... ... City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert in ... apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer from ... bones. This surgery is performed to correct the alignment of the jaw. It is beneficial ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Automation is one of the best ... growing demands for productivity in speed, accuracy, throughput and ... already adept of a wide range of functions that ... Instrumentation continues to evolve, and is poised to tackle ... years ago. Originally used mostly by the big pharmaceutical ...
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
Breaking Medicine Technology: